FDA — authorised 30 April 2009
- Application: BLA020725
- Marketing authorisation holder: ABBVIE
- Status: supplemented
🇺🇸 Creon in United States
FDA authorised Creon on 30 April 2009
Marketing authorisations
FDA
- Status: approved
Creon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Creon approved in United States?
Yes. FDA authorised it on 30 April 2009; FDA has authorised it.
Who is the marketing authorisation holder for Creon in United States?
ABBVIE holds the US marketing authorisation.